Microbiological Evaluation of the Ocular Flora Before Cataract Surgery
NCT ID: NCT02124603
Last Updated: 2016-01-18
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
120 participants
OBSERVATIONAL
2014-04-30
2014-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Health Assessment of Cataract Patients' Ocular Surface
NCT01016405
Dry Eye Syndrome Description During Cataract Surgery, With Multimodal Analysis of the Ocular Surface
NCT03923244
Compression of the Lid Margin Increase Microbial Contamination Risk of Patients Undergoing Cataract Surgery
NCT01859910
Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population
NCT05157113
Identification of Clinical, Biometrical and Operatory Factors Related to Pain During Cataract Surgery
NCT04353843
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
single group
Patients undergone cataract surgery
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \> 18 years
* Any gender and race
* Willing to sign informed consent
Exclusion Criteria
* Any ocular infection within 3 months
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
SIFI SpA
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marcello Santocono, MD
Role: PRINCIPAL_INVESTIGATOR
Casa Di Cura Di Stefano Catania (Italy)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Casa di Cura Di Stefano
Catania, Catania, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
041SI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.